Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Surface Oncology, Inc. | Chief Medical Officer | Common Stock | 0 | $0.94 | Sep 8, 2023 | Direct | |
Surface Oncology, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 0 | Sep 8, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SURF | Surface Oncology, Inc. | Sep 8, 2023 | 2 | $0 | 4 | Sep 8, 2023 | Chief Medical Officer |
SURF | Surface Oncology, Inc. | Aug 1, 2023 | 1 | -$6.62K | 4 | Aug 11, 2023 | Chief Medical Officer |
SURF | Surface Oncology, Inc. | Mar 1, 2023 | 1 | $0 | 4 | Mar 3, 2023 | Chief Medical Officer |
SURF | Surface Oncology, Inc. | Aug 3, 2022 | 1 | -$7.68K | 4 | Aug 5, 2022 | Chief Medical Officer |
SURF | Surface Oncology, Inc. | Mar 1, 2022 | 2 | $0 | 4 | Mar 3, 2022 | Chief Medical Officer |
SURF | Surface Oncology, Inc. | Mar 1, 2020 | 2 | -$90.3K | 4 | Jan 14, 2022 | Chief Medical Officer |